Index - P/E - EPS (ttm) -19.39 Insider Own 12.62% Shs Outstand 1.45M Perf Week 46.05%
Market Cap 28.94M Forward P/E - EPS next Y -3.81 Insider Trans 16.14% Shs Float 1.28M Perf Month 332.10%
Income -34.20M PEG - EPS next Q -2.74 Inst Own 53.88% Short Float 0.27% Perf Quarter 153.72%
Sales 0.00M P/S - EPS this Y 40.76% Inst Trans -5.78% Short Ratio 0.01 Perf Half Y 26.66%
Book/sh 6.42 P/B 3.08 EPS next Y 74.31% ROA -103.90% Short Interest 0.00M Perf Year 71.12%
Cash/sh 11.19 P/C 1.77 EPS next 5Y - ROE -137.40% 52W Range 4.11 - 21.25 Perf YTD -3.66%
Dividend Est. - P/FCF - EPS past 5Y 51.36% ROI -365.10% 52W High -6.87% Beta 0.76
Dividend TTM - Quick Ratio 2.06 Sales past 5Y -20.00% Gross Margin - 52W Low 381.51% ATR (14) 2.19
Dividend Ex-Date - Current Ratio 2.06 EPS Y/Y TTM 37.42% Oper. Margin 0.00% RSI (14) 95.15 Volatility 30.09% 18.68%
Employees 9 Debt/Eq 0.00 Sales Y/Y TTM - Profit Margin - Recom 1.00 Target Price 107.00
Option/Short No / Yes LT Debt/Eq 0.00 EPS Q/Q 30.90% Payout - Rel Volume 0.56 Prev Close 16.68
Sales Surprise - EPS Surprise 28.32% Sales Q/Q - Earnings Nov 14 AMC Avg Volume 496.01K Price 19.79
SMA20 132.41% SMA50 202.17% SMA200 59.07% Trades
Volume 277,664 Change 18.65%
Date
Action
Analyst
Rating Change
Price Target Change
Apr-08-24 Upgrade Ladenburg Thalmann
Neutral → Buy
$2.75
Sep-20-21 Upgrade Chardan Capital Markets
Sell → Buy
$4 → $3.50
Sep-03-21 Downgrade Truist
Buy → Hold
$4
Sep-03-21 Downgrade Ladenburg Thalmann
Buy → Neutral
Sep-03-21 Downgrade Chardan Capital Markets
Buy → Sell
$105 → $4
Sep-03-21 Downgrade B. Riley Securities
Buy → Neutral
$3
May-14-21 Initiated B. Riley Securities
Buy
$73
Mar-26-21 Initiated Citigroup
Buy
$75
Aug-28-20 Upgrade Chardan Capital Markets
Neutral → Buy
$45
Aug-25-20 Initiated Truist
Buy
$70
Nov-25-24 09:00AM
09:00AM
Nov-20-24 09:00AM
Nov-14-24 04:01PM
Aug-26-24 11:51AM
09:54PM
Loading…
Aug-14-24 09:54PM
(InvestorPlace) -7.80%
-20.51%
04:01PM
Jul-15-24 10:26AM
09:35AM
May-17-24 04:05PM
May-13-24 09:54PM
04:05PM
Mar-25-24 12:00PM
Mar-19-24 06:53AM
Mar-18-24 04:05PM
07:21AM
Loading…
Dec-04-23 07:21AM
Dec-01-23 04:01PM
Nov-13-23 04:01PM
Sep-14-23 10:50AM
Sep-06-23 03:15PM
Aug-25-23 08:00AM
Aug-14-23 04:01PM
Aug-01-23 04:01PM
Jun-20-23 08:00AM
May-19-23 04:01PM
May-15-23 04:01PM
Mar-31-23 04:05PM
Jan-12-23 04:05PM
Nov-14-22 04:01PM
04:01PM
08:00AM
Loading…
Aug-17-22 08:00AM
Aug-15-22 04:05PM
Jul-08-22 07:16AM
Jun-07-22 09:00AM
09:00AM
May-16-22 09:00AM
Dec-15-21 05:55AM
Sep-09-21 06:15PM
Sep-08-21 08:51AM
Sep-07-21 09:40PM
Sep-06-21 12:42PM
Sep-03-21 07:42PM
(Business Wire) -82.30%
-17.19%
02:14PM
11:15AM
Sep-02-21 04:05PM
Aug-16-21 04:05PM
(Business Wire) -6.11%
+12.23%
Aug-02-21 04:01PM
Jul-12-21 04:01PM
Jul-07-21 10:02AM
Jul-01-21 04:01PM
May-14-21 03:06AM
May-10-21 04:05PM
02:30PM
May-03-21 04:30PM
Mar-25-21 08:42AM
Mar-24-21 08:00AM
06:30AM
Mar-17-21 04:05PM
Feb-23-21 04:01PM
Feb-18-21 04:01PM
(Business Wire) -9.24%
+5.27%
Feb-13-21 03:18AM
Feb-12-21 04:01PM
Dec-02-20 11:26PM
Nov-24-20 04:05PM
Nov-16-20 04:05PM
Nov-15-20 09:00AM
Nov-10-20 04:05PM
Nov-09-20 04:05PM
02:30PM
Nov-02-20 04:30PM
04:05PM
Oct-29-20 08:00AM
Oct-28-20 04:09PM
Oct-26-20 08:30AM
Sep-29-20 09:00AM
Sep-16-20 08:48AM
Sep-09-20 04:01PM
(Business Wire) +9.47%
+11.13%
Aug-25-20 08:30AM
Aug-10-20 04:00PM
(Business Wire) +8.66%
-13.82%
Aug-03-20 09:00AM
Jul-28-20 08:30AM
Jun-18-20 08:30AM
Forte Biosciences, Inc. is a biopharmaceutical company, which engages in the provision of dermatology products and services. The firm's lead product includes FB-401, which is a live biotherapeutic for the treatment of inflammatory skin disease, including pediatric and adult patients with atopic dermatitis. The company was founded by Paul A. Wagner in 2017 and is headquartered in Dallas, TX.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Riley Antony A CHIEF FINANCIAL OFFICER Nov 21 '24 Buy 5.55 22,514 124,998 30,776 Nov 22 05:45 PM Riley Antony A CHIEF FINANCIAL OFFICER Oct 01 '24 Option Exercise 0.00 375 0 8,395 Oct 02 06:21 PM Wagner Paul A. SEE REMARKS Oct 01 '24 Option Exercise 0.00 1,250 0 77,568 Oct 02 06:19 PM Riley Antony A CHIEF FINANCIAL OFFICER Jul 01 '24 Option Exercise 0.00 9,375 0 203,849 Jul 03 12:18 PM Wagner Paul A. SEE REMARKS Jul 01 '24 Option Exercise 0.00 31,250 0 1,910,424 Jul 03 12:17 PM Riley Antony A CHIEF FINANCIAL OFFICER Apr 01 '24 Option Exercise 0.00 9,375 0 197,819 Apr 02 06:32 PM Wagner Paul A. SEE REMARKS Apr 01 '24 Option Exercise 0.00 31,250 0 1,881,627 Apr 02 06:31 PM Chen Hubert C See remarks Jan 01 '24 Option Exercise 0.00 7,500 0 96,478 Jan 03 04:04 PM Riley Antony A Chief Financial Officer Jan 01 '24 Option Exercise 0.00 9,375 0 192,285 Jan 03 04:02 PM Wagner Paul A. See Remarks Jan 01 '24 Option Exercise 0.00 31,250 0 1,854,486 Jan 03 04:01 PM Wagner Paul A. See Remarks Dec 18 '23 Buy 0.75 10,000 7,525 1,823,236 Dec 20 10:56 AM Wagner Paul A. See Remarks Dec 13 '23 Buy 0.70 10,520 7,351 1,803,236 Dec 15 06:29 PM Wagner Paul A. See Remarks Dec 14 '23 Buy 0.72 10,000 7,200 1,813,236 Dec 15 06:29 PM Wagner Paul A. See Remarks Dec 11 '23 Buy 0.65 25,000 16,188 1,787,940 Dec 12 07:30 PM Wagner Paul A. See Remarks Dec 12 '23 Buy 0.65 4,776 3,088 1,792,716 Dec 12 07:30 PM Wagner Paul A. See Remarks Dec 07 '23 Buy 0.58 36,203 21,168 1,747,940 Dec 08 07:20 PM Wagner Paul A. See Remarks Dec 08 '23 Buy 0.62 15,000 9,300 1,762,940 Dec 08 07:20 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite
